Literature DB >> 111294

Brain tryptophan metabolism in schizophrenia: a post mortem study of metabolites of the serotonin and kynurenine pathways in schizophrenic and control subjects.

M H Jospeh, H F Baker, T J Crow, G J Riley, D Risby.   

Abstract

Serotonin (5HT), its chief metabolite 5-hydroxyindoleacetic acid (5 HIAA), its precursor tryptophan, and kynurenine, another metabolite of tryptophan, have been measured in post mortem human brain samples. Concentrations of these metabolites were not found to be significantly different in putamen, hippocampus or temporal cortex from 23 normal subjects compared with 15 subjects in whom a diagnosis of schizophrenia could be restrospectively confirmed. The results have been analysed with respect to cause of death, medication and post mortem changes. Post mortem increases in tryptophan and kynurenine were observed. Some interrelationships between the variables measured within and between the different areas studied are discussed. It is concluded that there is no evidence for a generalised deficit of 5HT in the brain in schizophrenia, nor for gross changes in turnover along the serotonin or kynurenine pathways of tryptophan metabolism in brain.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 111294     DOI: 10.1007/bf00431959

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  39 in total

1.  Transmitter precursors and metabolites in human ventricular cerebrospinal fluid.

Authors:  G Curzon; B D Kantamaneni; J R Bartlett; P K Bridges
Journal:  J Neurochem       Date:  1976-03       Impact factor: 5.372

2.  A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

Authors:  D W Woolley; E Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  1954-04       Impact factor: 11.205

3.  Regional serotonin levels in brain: a comparison of depressive suicides and alcoholic suicides with controls.

Authors:  E Cochran; E Robins; S Grote
Journal:  Biol Psychiatry       Date:  1976-06       Impact factor: 13.382

4.  Free and bound serum tryptophan in drug-free normal controls and chronic schizophrenic patients.

Authors:  E F Domino; R R Krause
Journal:  Biol Psychiatry       Date:  1974-06       Impact factor: 13.382

5.  Cerebral tryptophan-2,3-dioxygenase (pyrrolase) and its induction in rat brain.

Authors:  E M Gál
Journal:  J Neurochem       Date:  1974-05       Impact factor: 5.372

6.  Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and homovanillic acid in brain tissue from an autopsy material.

Authors:  C G Gottfries; B E Roos; B Winblad
Journal:  Acta Psychiatr Scand       Date:  1974       Impact factor: 6.392

7.  Relationship of dietary tryptophan and niacin to tryptophan metabolism in schizophrenics and nonschizophrenics.

Authors:  I R Payne; E M Walsh; E J Whittenburg
Journal:  Am J Clin Nutr       Date:  1974-06       Impact factor: 7.045

8.  Error in the determination of tryptophan by the method of Denkla and Dewey. A revised procedure.

Authors:  D L Bloxam; W H Warren
Journal:  Anal Biochem       Date:  1974-08       Impact factor: 3.365

9.  Clinical effects of tryptophan in chronic schizophrenic patients.

Authors:  J C Gillin; J A Kaplan; R J Wyatt
Journal:  Biol Psychiatry       Date:  1976-10       Impact factor: 13.382

10.  Behavioral changes of chronic schizophrenic patients given L-5-hydroxytryptophan.

Authors:  R J Wyatt; T Vaughan; M Galanter; J Kaplan; R Green
Journal:  Science       Date:  1972-09-22       Impact factor: 47.728

View more
  12 in total

1.  Kynurenine is correlated with IL-1β in plasma of schizophrenia patients.

Authors:  Helena P G Joaquim; Alana C Costa; Wagner F Gattaz; Leda Leme Talib
Journal:  J Neural Transm (Vienna)       Date:  2018-01-06       Impact factor: 3.575

Review 2.  The biology of schizophrenia.

Authors:  T J Crow
Journal:  Experientia       Date:  1982-11-15

Review 3.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

4.  Proceeding of the British Pharmacological Society, Clinical Pharmacology Section, 16-18th December, 1980, University of London. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 5.  Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders.

Authors:  Michael Y Bai; David B Lovejoy; Gilles J Guillemin; Rouba Kozak; Trevor W Stone; Maju Mathew Koola
Journal:  Complex Psychiatry       Date:  2021-02-08

6.  Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation.

Authors:  G Bucht; R Adolfsson; C G Gottfries; B E Roos; B Winblad
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

7.  Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats.

Authors:  Marco Bortolato; Roberto Frau; Marco Orrù; Maria Collu; Giampaolo Mereu; Manolo Carta; Fabio Fadda; Roberto Stancampiano
Journal:  Psychopharmacology (Berl)       Date:  2008-03-12       Impact factor: 4.530

8.  Studies on kynurenine in human cerebrospinal fluid: lowered levels in epilepsy.

Authors:  S N Young; M H Joseph; S Gauthier
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

Review 9.  The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine.

Authors:  J N Joyce
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 10.  The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.

Authors:  D C Ohuoha; T M Hyde; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.